![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Daehe Biopharma Co., Ltd. Siheung City Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Levodropropizine, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2012-401 - Rev 00
This Chemical Type CEP, issued on April 24, 2014, remains in force until April 24, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 1535 associated with this CEP further emphasizes